Microchip Technology
MCHP
$66.54 0.62%
Exchange: NASDAQ | Sector: Technology | Industry: Semiconductors
Q2 2025
Published: Nov 5, 2024

Earnings Highlights

  • Revenue of $1.16B down 48.4% year-over-year
  • EPS of $0.14 decreased by 87.8% from previous year
  • Gross margin of 57.4%
  • Net income of 78.40M
  • ""Excluding the benefit of the legal settlement, our September quarter results were consistent with our guidance with net sales down 7.3% sequentially as we navigate through an inventory correction and macro weakness in manufacturing."" - Ganesh Moorthy

Microchip Technology Incorporated (MCHP) QQ2 2025 Results: Navigating Inventory Destocking Amid AI/Data Center Growth and CHIPS Act Ambitions

Executive Summary

Microchip Technology reported a QQ2 2025 quarter characterized by a continued inventory correction and macro weakness across much of the industrial end market, with notable resilience in AI/data center and aerospace/defense segments. On a reported basis, net sales were $1.164 billion, down 6.2% sequentially, while GAAP gross margins were 57.4% and non-GAAP gross margins were just above 59% (midpoint guidance). The company highlighted a $21.4 million total cost impact from a cybersecurity incident and a $25.9 million capacity underutilization charge, illustrating the near-term profitability drag from underutilized capacity in a weak demand environment. Excluding the legal settlement benefit, September quarter results were essentially in line with guidance, with non-GAAP net income of $250.2 million and non-GAAP diluted EPS of $0.46, modestly above the midpoint of guidance due to the settlement tailwind (+$0.02). Management signaled an improving design-in pipeline and highlighted AI/data center, aerospace/defense, and automotive/industrial opportunities as longer‑term growth engines, while cautioning that December is historically the weakest quarter and that macro uncertainty remains a headwind. In the near term, the company is guiding for December net sales of $1.025–$1.095 billion, with non-GAAP gross margin of 57–59% and non-GAAP operating margin of 22.2–25.8%; non-GAAP EPS guidance of $0.25–$0.35. The results underscore a cyclical recovery path rather than a structural expansion, with meaningful leverage to an upcycle should demand re-accelerate and channel destocking unwind. The capital-return program remains robust, with the company returning $261 million to shareholders in Q2 and targeting 100% of adjusted free cash flow to be returned going forward, albeit with occasional balance-sheet levers to manage the dividend in tight quarters.

Key Performance Indicators

Revenue

1.16B
QoQ: -6.24% | YoY:-48.37%

Gross Profit

668.50M
57.44% margin
QoQ: -9.28% | YoY:-56.23%

Operating Income

146.60M
QoQ: -33.09% | YoY:-83.44%

Net Income

78.40M
QoQ: -39.37% | YoY:-88.24%

EPS

0.15
QoQ: -37.50% | YoY:-87.80%

Revenue Trend

Margin Analysis

Key Insights

  • QQ2 2025 net sales: $1.164 billion; QoQ change: -6.2% (sequential). YoY comparison not explicitly stated in the call but 4-quarter revenue shows pronounced declines in the recent period.
  • GAAP gross margin: 57.4%; Non-GAAP gross margin: just above midpoint guidance at 59.5% (including $25.9 million capacity underutilization charges). Excluding the license settlement, non-GAAP gross margin would be 59.1%.
  • Operating margin: GAAP operating margin 12.6%; Non-GAAP operating margin 28.5% (midpoint of guidance, excluding settlement).
  • Net income: GAAP net income $78.4 million; Non-GAAP net income $250.2 million; Non-GAAP EPS $0.46 (beat by $0.03 at the guidance midpoint).
  • EBITDA: GAAP EBITDA $338.2 million; Adjusted EBITDA $405.7 million (34.9% of net sales).

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 1,075.50 -0.09 -13.4% View
Q4 2025 970.50 -0.29 -26.8% View
Q3 2025 1,026.00 -0.10 -41.9% View
Q2 2025 1,163.80 0.14 -48.4% View
Q1 2025 1,241.30 0.24 -45.8% View